🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCalgary compounding pharmacies — 12 month update Page 7

Calgary compounding pharmacies — 12 month update

NeuroNate Wed, May 29, 2024 at 11:45 PM 50 replies 2,566 viewsPage 7 of 10
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Jun 4, 2024 at 1:35 PM#31

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Last edited: Jun 4, 2024 at 6:35 PM
47 22wei_SG, cory_ATX, lori_vegas and 44 others
Reply Quote Save Share Report
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Jun 4, 2024 at 8:49 PM#32
Dr.RenalNash said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding a me-too, because a thread of one person's experience is not much use. I had assumed I was the exception until I read this.

46 21SaraMom3, Dr.MetabolicMD, RetaRick_CA and 43 others
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Jun 5, 2024 at 4:03 AM#33
Dr.RenalNash said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

There is a second half to this that has not been said yet. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Last edited: Jun 5, 2024 at 7:03 AM
45 20DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Jun 5, 2024 at 11:17 AM#34

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Ask again with the specifics and you will get a better answer than this one.

44 19PharmHunterJen, TomTeleRx, DoseLogDan and 41 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Jun 5, 2024 at 6:32 PM#35

Following on from Dr.RenalNash — and this may be the naive question:

Was that from a primary source or from a summary of one?

Last edited: Jun 5, 2024 at 10:32 PM
43 18ZaraB_AL, JakeSmashed95, NauseaFreeNow and 40 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register